This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have the most supplementa…
Which drugs have the most supplementary protection certificates? Read Post »
COMPLERA (emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate) Gilead sciences inc Patent: 6,703,396 Expiration: Sep 9, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical…
The post Drug Pat…
Drug Patent Expirations for the Week of September 5, 2021 Read Post »
This chart shows the drugs with the most patents in Lithuania. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Lithu…
Which pharmaceutical drugs have the most drug patents in Lithuania? Read Post »
Annual Drug Patent Expirations for MINOLIRA Minolira is a drug marketed by Epi Hlth and is included in one NDA. The generic ingredient in MINOLIRA is minocycline hydrochloride. Additional details…
The post New patent for Epi Hlth drug MINOLIRA appeared…
Annual Drug Patent Expirations for QUILLICHEW+ER Quillichew Er is a drug marketed by Nextwave Pharms and is included in one NDA. It is available from two suppliers. There are seven…
The post New patent for Nextwave Pharms drug QUILLICHEW ER appeared fi…
New patent for Nextwave Pharms drug QUILLICHEW ER Read Post »
This chart shows the pharmaceutical companies with the most patents in Poland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Poland? Read Post »
Annual Drug Patent Expirations for OLINVYK Olinvyk is a drug marketed by Trevena and is included in one NDA. There are three patents protecting this drug. This drug has thirty-five…
The post New patent for Trevena drug OLINVYK appeared first on DrugPat…
Annual Drug Patent Expirations for CLEVIPREX Cleviprex is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent for Chiesi drug CLEVIPREX appeared first on Drug…
This chart shows the pharmaceutical companies with the most tentative generic drug approvals in 2020 The Food and Drug Administration (FDA) grants tentative approvals to generic entrants when their generic…
The post Generic companies with the most tent…
Generic companies with the most tentative approvals Read Post »
Annual Drug Patent Expirations for CABOMETYX Cabometyx is a drug marketed by Exelixis Inc and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent for Exelixis Inc drug CABOMETYX appeared first on DrugPa…
Get new actionable insights and updates from BiotechBlog
